.After revealing a phase 3 launch based on good midstage outcomes, iTeos and also GSK are finally di...
.The FDA must be much more available as well as collaborative to let loose a rise in approvals of un...
.It is actually an extraordinarily occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and a...
.Atea Pharmaceuticals' antiviral has actually stopped working another COVID-19 test, however the bio...
.Neurocrine Biosciences' mental illness plan pivot has actually stopped working. The biotech was una...
.Sanofi has created a late access to the radioligand event, paying 100 thousand euros ($ 110 thousan...
.After F2G's first attempt to get a brand-new class of antifungal to market was thwarted due to the ...
.Moderna has promised to reduce R&D costs through $1.1 billion by 2027. The choice to shrink the ...
.Simply four months after Sanofi wager $80 million in upfront cash money on Pivot Therapies' losmapi...
.Cancer cells business Oncternal Therapies is folding all its professional trials as well as laying ...